Search this site
Embedded Files
DEKODE
  • Home
    • ABCD Sanofi DKA collaborative Project
    • DEKODE HHS
    • DEKODE Hypoglycaemia
    • DEKODE DKA
    • ABCD DEKODE Hypoglycaemia
  • Publications
  • DEKODE Team
DEKODE
  • Home
    • ABCD Sanofi DKA collaborative Project
    • DEKODE HHS
    • DEKODE Hypoglycaemia
    • DEKODE DKA
    • ABCD DEKODE Hypoglycaemia
  • Publications
  • DEKODE Team
  • More
    • Home
      • ABCD Sanofi DKA collaborative Project
      • DEKODE HHS
      • DEKODE Hypoglycaemia
      • DEKODE DKA
      • ABCD DEKODE Hypoglycaemia
    • Publications
    • DEKODE Team

Criteria for abstracts and publications: 

Click here for detailed criteria to be an author for abstracts and publications in DEKODE.

Click here for the list of our previous national and international presentations

Publications

9. Clinical characteristics and outcomes of diabetes-related ketoacidosis (DKA) in sodium-glucose co-transporter-2 inhibitor (SGLT2i) users with type 2 diabetes

Angelica Sharma, Shams Ali Baig, Rasiah Thayakaran, Lakshmi Rengarajan, Nevil C Philip, Anu Ann Abraham, Aspasia Manta, Parth Narendran, Ketan Dhatariya, Guillermo E Umpierrez, Punith Kempegowda; DEVI collaboration.

Diabetes Obes Metab. 2025 Sep


8. Simulation-based training significantly improved confidence and clinical skills of resident doctors in acute diabetes management

Kalyaani Persad, Aqeelah Khatoon, Aashritha Buchipudi, Amanda Ling Jie Yee, Nevil C. Philip, Angelica Sharma, Akshat Sinha, Sofia Salahuddin, Punith Kempegowda, DEVI collaboration.

Diabetic Medicine. 2025. 


7. DEKODE—A cloud-based performance feedback model improved DKA care across multiple hospitals in the UK

Lakshmi N. Rengarajan, Catherine Cooper, Kashish Malhotra, Angelica Sharma, Nevil Philip, Anu Ann Abraham, Ketan Dhatariya, Parth Narendran, Punith Kempegowda, DEKODE and DEVI Group. 

Diabetic Medicine. 2025. 


6. Guidelines for the management of diabetes-related ketoacidosis (DKA) have been poorly adopted and implemented, resulting in a lack of improvement in outcomes. 

Sharma A, Rengarajan L, Narendran P, Dhatariya K, Kempegowda P. 

Diabetic Medicine. 2025.


5. Determining factors influencing hospital stay for individuals admitted with diabetes-related ketoacidosis - findings from DEKODE length of stay quality improvement project. 

Gupta A, Brazier B, Rengarajan L, Narendran P, Kempegowda P. 

Clinical Medicine. 2024.


4. Clinical and biochemical profile of 786 sequential episodes of diabetic ketoacidosis in adults with type 1 and type 2 diabetes mellitus. 

Ooi E, Nash K, Rengarajan L, Melson E, Thomas L, Johnson A, Zhou D, Wallett L, Ghosh S, Narendran P, Kempegowda P.

BMJ Open Diabetes Res Care. 2021. 


3. Effect of covid-19 on the clinical course of diabetic ketoacidosis (DKA) in people with type 1 and type 2 diabetes.

Kempegowda P, Melson E, Johnson A, Wallett L, Thomas L, Zhou D, Holmes C, Juszczak A, Karamat MA, Ghosh S, Hanif W, Narendran P, Bellary S. 

Endocrine Connections. 2021.


2. Regular performance feedback may be key to maintain good quality DKA management: results from a five-year study. 

Kempegowda P, Chandan JS, Coombs B, De Bray A, Jawahar N, James S, Ghosh S, Narendran P. 

BMJ Open Diabetes Res Care. 2019 Aug. 


  1. Regular and frequent feedback of specific clinical criteria delivers a sustained improvement in the management of diabetic ketoacidosis. 

Kempegowda P, Coombs B, Nightingale P, Chandan JS, Al-Sheikhli J, Shyamanur B, Theivendran K, Melapatte AV, Salanke U, Akber M, Ghosh S, Narendran P. 

Clinical Medicine. 2017

Google Sites
Report abuse
Page details
Page updated
Google Sites
Report abuse